Effect of growth hormone on high plasma levels of glucagon-like peptide-1 (GLP-1) in hypophysectomized rats

被引:4
|
作者
Tateishi, K
Kitayama, N
Ishikawa, H
Mitsudome, A
Hirose, S
机构
[1] Fukuoka Univ, Sch Med, Dept Biochem, Jonan Ku, Fukuoka 8140180, Japan
[2] Fukuoka Univ, Sch Med, Dept Pediat, Fukuoka 81401, Japan
[3] JCR Pharmaceut Co Ltd, Kobe, Hyogo, Japan
关键词
hypophysectomized rat; plasma GLP-1; GH; oral glucose tolerance test;
D O I
10.1055/s-2002-34994
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Fasting plasma GLP-1 levels were significantly higher in hypophysectomized (hypox) rats (n=6) than in intact (normal) rats (n=7) (54.3+/-5.2 vs. 33.3+/-2.4 pmol/L, p<0.001). To examine the influence of pituitary hormones on plasma GLP-1 levels, concentrations of plasma glucose, insulin and GLP-1 after an oral glucose load to hypox rats that were given either rat growth hormone (rGH) (n=7), cortisol and thyroxine (n=7) or no substitution (n=6) were compared with those of normal rats (n=7). Plasma glucose levels in the fasting state and after the glucose ingestion were significantly lower in hypox rats, but the patterns were different from those in normal rats. Insulin levels both in the fasting state and after the glucose ingestion were significantly decreased in hypox rats and the fasting and total GLP-1 levels were significantly increased in those rats. rGH substitution significantly increased the total insulin levels in hypox rats and decreased the fasting and total GLP-1 levels closely to levels in normal rats, while substitution with cortisol and thyroxine failed to introduce such a significant effect. These results suggested that secretion of GLP-1 might be influenced by the function of GH.
引用
收藏
页码:361 / 363
页数:3
相关论文
共 50 条
  • [41] Splenic Artery Thrombosis and Glucagon-like Peptide-1 (GLP-1) Agonist: Is There an Association?
    Lee, Regis
    Alukal, Joseph J.
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2024, 119 (10S): : S2966 - S2967
  • [42] Interactions of glucagon-like peptide-1 (GLP-1) with the blood-brain barrier
    Kastin, AJ
    Akerstrom, V
    Pan, WH
    JOURNAL OF MOLECULAR NEUROSCIENCE, 2002, 18 (1-2) : 7 - 14
  • [43] Glucagon-like peptide-1 (GLP-1) mediates cardioprotection by remote ischaemic conditioning
    Basalay, Marina V.
    Mastitskaya, Svetlana
    Mrochek, Aleksander
    Ackland, Gareth L.
    del Arroyo, Ana Gutierrez
    Sanchez, Jenifer
    Sjoquist, Per-Ove
    Pernow, John
    Gourine, Alexander V.
    Gourine, Andrey
    CARDIOVASCULAR RESEARCH, 2016, 112 (03) : 669 - 676
  • [44] Molecular simulation of zwitterionic polypeptides on protecting glucagon-like peptide-1 (GLP-1)
    Teng, Jiaman
    Liu, Yuting
    Shen, Zhuanglin
    Lv, Weizhong
    Chen, Yantao
    INTERNATIONAL JOURNAL OF BIOLOGICAL MACROMOLECULES, 2021, 174 : 519 - 526
  • [45] Release of glucagon-like peptide-1 (GLP-1) by carbohydrates in the perfused rat ileum
    U. Ritzel
    A. Fromme
    M. Ottleben
    U. Leonhardt
    G. Ramadori
    Acta Diabetologica, 1997, 34 : 18 - 21
  • [46] CLONING AND FUNCTIONAL EXPRESSION OF THE HUMAN GLUCAGON-LIKE PEPTIDE-1 (GLP-1) RECEPTOR
    DILLON, JS
    TANIZAWA, Y
    WHEELER, MB
    LENG, XH
    LIGON, BB
    RABIN, DU
    YOOWARREN, H
    PERMUTT, MA
    BOYD, AE
    ENDOCRINOLOGY, 1993, 133 (04) : 1907 - 1910
  • [47] Gastrointestinal effects of glucagon-like peptide-1 (GLP-1): Mechanism of action.
    Holst, JJ
    Wojdemann, M
    Wettergren, A
    DIABETES, 1996, 45 : 859 - 859
  • [48] Glucagon-like Peptide-1 (GLP-1): 25 Years Incentive for Diabetes research
    Nauck, M. A.
    DIABETOLOGIE UND STOFFWECHSEL, 2012, 7 (05) : 367 - 372
  • [49] Glucagon-like Peptide-1 (GLP-1) and neurotransmitters signaling in epilepsy: An insight review
    Koshal, Prashant
    Jamwal, Sumit
    Kumar, Puneet
    NEUROPHARMACOLOGY, 2018, 136 : 271 - 279
  • [50] New insights into the role of cAMP in the production and function of the incretin hormone glucagon-like peptide-1 (GLP-1)
    Yu, Zhiwen
    Jin, Tianru
    CELLULAR SIGNALLING, 2010, 22 (01) : 1 - 8